Related Experiment Video
Updated: Dec 28, 2025
14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
Amanda M Smith1,2, Christine R C Zhang1,2, Alexandre S Cristino1,3
1The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Australia.
Oncotarget
|February 21, 2020
Abstract:
[This corrects the article DOI: 10.18632/oncotarget.27206.].
Insights
This study corrects a previous article DOI. The updated information ensures accurate citation and retrieval of scientific research on cancer targets.
Area of Science:
- Oncology
- Biomedical Research
Context:
- Correction of a previously published article DOI.
- Ensuring accurate referencing in scientific literature.
Purpose:
- To provide the correct Digital Object Identifier (DOI) for a specific article.
- To facilitate proper citation and access to research findings.
Summary:
- The article DOI: 10.18632/oncotarget.27206 has been corrected.
- This ensures researchers can accurately locate and cite the relevant study.
Impact:
- Improved accuracy in scientific referencing.
- Enhanced discoverability of published research.
- Facilitation of scientific discourse and collaboration.
Related Concept Videos
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K